Is BioNexus Gene Lab stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for BioNexus Gene Lab 10 years ago, but if you had invested on Wednesday 16th of September 2020 when the price was $0.410, you would have made a loss of $-0.0346 per share or -8.44%
No, the average daily trading liquidity for BioNexus Gene Lab is $393 115 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
BioNexus Gene Lab has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for BioNexus Gene Lab to be medium [0.7 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.